Subscribe To
Neuronetics: numerous expansion opportunities mean an outperforming stock
The high prevalence of major depressive disorder creates the need for Neuronetics' neurostar Advanced T...
November 28, 2022, 2:07 pm
Neuronetics to present at the piper sandler 34th annual healthcare conference
MALVERN, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, ...
November 21, 2022, 4:30 pm
Neuronetics announces neurostar® advanced therapy for mental health system innovations
Enhancements further establish the Company’s leadership position as the top transcranial magnetic stimulation therapy MALVERN, Pa., Nov. 14, 2022 (G...
November 14, 2022, 1:33 pm
Read why neuronetics shares are trading higher today
The FDA has cleared Neuronetics Inc's (NASDAQ: STIM) neurostar Advanced Therapy for Mental Health �...
July 19, 2022, 8:00 am
Neuronetics posts better than expected q4 results despite lower neurostar therapy system sales
Neuronetics Inc (NASDAQ: STIM) reported Q4 FY21 sales of $15.02 million, down 4% Y/Y, exceeding previously issued guidance of $13.0 million - $14.0 ...
March 8, 2022, 3:16 pm